We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+452.52%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.17%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAM
4551
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$563K ﹤0.01%
93,751
-11,133
-11% -$62.7K
SAND
4552
DELISTED
Sandstorm Gold
SAND
$562K ﹤0.01%
106,783
+10,102
+10% +$51.6K
ATRC icon
4553
AtriCure
ATRC
$2.23B
$561K ﹤0.01%
12,639
+6,756
+115% +$282K
DNA icon
4554
Ginkgo Bioworks
DNA
$469M
$561K ﹤0.01%
8,295
+635
+8% +$58.4K
ECVT icon
4555
Ecovyst
ECVT
$1.14B
$560K ﹤0.01%
63,245
+45,594
+258% +$420K
HEWU
4556
DELISTED
iShares Currency Hedged MSCI United Kingdom ETF
HEWU
$560K ﹤0.01%
22,636
+1,589
+8% +$38.6K
DSKE
4557
DELISTED
Daseke, Inc. Common Stock
DSKE
$560K ﹤0.01%
98,399
+2,536
+3% +$15K
BHC icon
4558
CALL
Bausch Health
BHC
$2.43B
$560K ﹤0.01%
89,100
-60,000
-40% -$419K
TRTX
4559
TPG RE Finance Trust
TRTX
$619M
$558K ﹤0.01%
82,250
-57,246
-41% -$422K
ETJ
4560
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$569M
$557K ﹤0.01%
74,298
+11,770
+19% +$96.1K
SLP icon
4561
Simulations Plus
SLP
$371M
$557K ﹤0.01%
15,223
+4,777
+46% +$201K
AGL icon
4562
Agilon Health
AGL
$1.61B
$555K ﹤0.01%
1,376
-68
-5% -$31.9K
CF icon
4563
PUT
CF Industries
CF
$17.9B
$554K ﹤0.01%
6,500
AMR icon
4564
Alpha Metallurgical Resources
AMR
$2.08B
$553K ﹤0.01%
3,780
+2,329
+161% +$368K
RCS
4565
PIMCO Strategic Income Fund
RCS
$249M
$553K ﹤0.01%
111,975
+4,113
+4% +$21K
CCNE icon
4566
CNB Financial Corp
CCNE
$1.03B
$553K ﹤0.01%
23,241
+22,786
+5,008% +$564K
IPO icon
4567
Renaissance IPO ETF
IPO
$165M
$552K ﹤0.01%
22,334
+3,527
+19% +$95.1K
GRFS
4568
Grifois
GRFS
$5.38B
$552K ﹤0.01%
64,898
-22,838
-26% -$166K
TEVA icon
4569
CALL
Teva Pharmaceuticals
TEVA
$42.7B
$551K ﹤0.01%
60,400
MLAB icon
4570
Mesa Laboratories
MLAB
$611M
$550K ﹤0.01%
3,312
+1,150
+53% +$180K
ELAN icon
4571
PUT
Elanco Animal Health
ELAN
$11.6B
$550K ﹤0.01%
45,000
-40,000
-47% -$499K
CDL icon
4572
VictoryShares US Large Cap High Div Volatility Wtd ETF
CDL
$410M
$549K ﹤0.01%
9,318
-741
-7% -$42.9K
IONQ icon
4573
IonQ
IONQ
$19B
$547K ﹤0.01%
158,585
+42,561
+37% +$205K
PFI icon
4574
Invesco Dorsey Wright Financial Momentum ETF
PFI
$60.7M
$547K ﹤0.01%
13,427
-15,533
-54% -$644K
MUST icon
4575
Columbia Multi-Sector Municipal Income ETF
MUST
$597M
$546K ﹤0.01%
+27,103
New +$538K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.